View Information Collection (IC)
View Information Collection (IC)

View Information Collection (IC)

Testing FDA's Drug Safety Communications with Consumers to Improve Consumer Knowledge about How FDA Communicates Risks and Benefits of Prescription Medicines
 
New
 
Voluntary
 

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Other-Screener DSC Focus Group Screener Final.docx No   Printable Only
Other-Moderator's guide DSC Moderator's Guide_Final OMB_.doc No   Printable Only

Health Consumer Health and Safety

 

216 0
   
Individuals or Households
 
   0 %

  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 216 0 216 0 0 0
Annual IC Time Burden (Hours) 432 0 432 0 0 0
Annual IC Cost Burden (Dollars) 0 0 0 0 0 0

Title Document Date Uploaded
DSC Example 1 testosterone DSC Example 1_testosterone_Final.docx 08/20/2014
DSC Example 2 Sodium Phosphate DSC Example 2_Sodium Phosphate_Final.docx 08/20/2014
DSC Example 3 Fentanyl DSC Example 3_fentanyl_Final.docx 08/20/2014
DSC Testosterone pdf DSC Testosterone.pdf 08/20/2014
DSC Sodium Phosphate pdf DSC Sodium Phosphate.pdf 08/20/2014
DSC Fentanyl DSC Fentanyl.pdf 08/20/2014
OMB Memo/Abbreviated supporting statement OMB_generic_FG_clearance2_0910-0677.doc 08/26/2014
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.